Complications of peptic ulcer;Complicaciones de la úlcera péptica

Medicine

Volumn 10, Issue 3, 2008, Pages 141-147

  Cecilio Irazola, A ^a   Cabrerizo Garcia J L ^a   Lanas Arbeloa, A ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO LOZANO BLESA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 42049101797     PISSN: 03045412     EISSN: 15788822     Source Type: Journal    
DOI: 10.1016/S0211-3449(08)72887-X     Document Type: Article

References (34)

1. Sainz R, Montoro M, Gomollon F. Úlcera duodenal. En: Vilardell F, Rodes J, editores. Enfermedades digestivas. Madrid: CEA S.A.; 1990. p. 721-44.
2. Gustavsson S, Nelly KA, Melton LJ 3rd, Zinsmeister AR. Trends in peptic ulcer surgery. A population-based study in Rochester, Minnesota, 1956-1985. Gastroenterology. 1988;94:688.
3. Penston JG, Wormsley KG. Review article: manteinance treatment with H2 receptor antagonists for peptic ulcer disease. Aliment Pharmacol Ther. 1992;6:3.
4. De Leest H, van Dieten H, van Tulder M, Lems WF, Dijkmans BA, Boers M. Costs of treating bleeding and perforated peptic ulcers in The Netherlands. J Rheumatol. 2004;31:788.
5. Swain CP, Storey DW, Bown SG, Heath J, Mills TN, Salmon PR, et al. Nature of the bleeding vessel in currently bleeding gastric ulcers. Gastroenterology. 1986;90:595-608.
6. Allan R, Dykes P. A study of the factors influencing mortality rates from gastrointestinal haemorrhage. Q J Med. 1976;45:533-50.
7. Vreeburg EM, Terwee CB, Snel P, Rauws EAJ, Bartelsman JFWM, Meulen JHP, et al. Validation of the rockall risk scoring system in upper gastrointestinal bleeding. Gut. 1999;44:331-5.
8. •• Feu F, Brullet E, Calvet X, Fernández-Llamazares J, Guardiola J, Moreno P, et al. Recomendaciones para el diagnóstico y el tratamiento de la hemorragia digestiva alta aguda no varicosa. Gastroenterol Hepatol. 2003;26(2):70-85.
9. Kovacs TOG, Sytnik B, Jensen DM, Walsh JH. A comparison of acid and gastrin secretion in bleeding and non-bleeding duodenal ulcer patients. Gastroenterology. 1991;100 Suppl A:101.
10. • Hosking SW, Yung MY, Chung SC, Li AKC. Differing prevalence of Helicobacter in bleeding and nonbleeding ulcers. Gastroenterology. 1992;102 Suppl A:85.
11. Gabriel SE, Jaakkimanen L, Bombardier C. Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs: a meta-analysis. Ann Intern Med. 1991;115:787-96.
12. Somerville K, Faulkner G, Langman M. Non-steroidal anti-inflammatory drugs and bleeding peptic ulcer. Lancet. 1986;1:462-4.
13. • Lanas A, García-Rodríguez LA, Arroyo MT, Gomollon F, Feu F, González-Pérez A, et al; Asociación Española de Gastroenterología. Risk of upper gastrointestinal ulcer bleeding associated with selective cyclo-oxygenase-2 inhibitors, traditional non-aspirin non-steroidal anti-inflammatory drugs, aspirin and combinations. Gut. 2006;55(12):1731-8.
14. •• Lanas A, Sekar MC, Hirschowitz BI. Objetive evidence of aspirin use in both ulcer and non-ulcer upper and lower gastrointestinal bleeding. Gastroenterology. 1992;103:862-9.
15. Griffin MR, Piper JM, Daugherty JR, Snowden M, Ray WA. Nonsteroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly persons. Ann Intern Med. 1991;114:257-63.
16. Shorrock CJ, Langman MJS, Warlow C. Risks of upper GI bleeding during TIA prophylaxis with aspirin. Gastroenterology. 1992;102 Suppl A:165.
17. Spechler SJ. Peptic Ulcers. En: Feldman M, Friedman LS, Sleisenger MH, editors. Gastrointestinal and Liver Disease. 7th ed. Philadelphia, PA: WB Saunders Company; 2002. p. 747-72.
18. Bickel WH, Bruttig SP, Millnamow MA, O'Benar J, Wade CE. The detrimental effects of intravenous crystalloid after aortotomy in swine. Surgery. 1991;110:529-36.
19. Campo R, Brullet E, Calvet X, Catot Ll, Cabrol J, Laporte E, et al. Safety of outpatient management of nonvariceal upper gastrointestinal bleeding: preliminary results of a randomized study. Gastrointest Endosc. 1998;17:AB81.
20. Walt RP, Cottrell J, Mann SG, Freemantle NP, Langman MJ. Continuous intravenous famotidine for haemorrhage from peptic ulcer. Lancet. 1992;340:1058-62.
21. Imperiale TF, Birgisson S. Somatostatin or octreotide compared with H2 antagonist and placebo in the management of acute non-variceal upper gastrointestinal haemorrhage: a meta-analysis. Ann Intern Med. 1997;127:1062-71.
22. Meier R, Wettstein AR. Treatment of acute nonvariceal upper gastrointestinal hemorrhage. Digestion. 1999;60:47-52.
23. • Gisbert JP, Boiseda D, Aller R, de la Serna C, Sanz E, Martin D, et al. Helicobacter pylori y hemorragia digestiva por úlcera duodenal: prevalencia de la infección, eficacia de tres terapias triples y papel de la erradicación en la prevención de la recidiva hemorrágica. Med Clin (Barc). 1999;112:161-5.
24. Gunshefski L, Flancbaum L, Brolin RE, Frankel A. Changing patterns in perforated peptic ulcer disease. Am Surg. 1990;56:270-4.
25. Paimela H, Paimela L, Myllykangas-Lousujärvi R, Kivilaakso E. Current features of peptic ulcer disease in Finland: incidence of surgery, hospital admissions and mortality for the disease during the past twenty-five years. Scand J Gastroenterol. 2002;37(4):399-403.
26. •• Lanas A, Serrano P, Bajador E, Esteva F, Benito R, Sáinz R. Evidence of aspirin use in both upper and lower gastrointestinal perforation. Gastroenterology. 1997;112:683-9.
27. Silen W. Cope's early diagnosis of the acute abdomen. New York: Oxford University Press; 1996.
28. Zittel TT, Jehle EC, Becker HD. Surgical management of peptic ulcer disease today: indication, technique and outcome. Langenbecks Arch Surg. 2000;385:84.
29. Norris JR, Haubrich WS. The incidence and clinical features of penetration in peptic ulceration. JAMA. 1961;178:386.
30. Tavenor T, Smith S, Sullivan S. Gastrocolic fistula: a review of 15 cases and an update in the literature. J Clin Gastroenterol. 1993;16(3):189-91.
31. Shone DN, Nikoomanesh P, Smith-Meek MM, Bender JS. Malignancy is the most common cause of gastric outlet obstruction in the era of H2 blockers. Am J Gastroenterol. 1995;90:1769-70.
32. • Taskin V, Gurer I, Ozyilkan E, Sare M, Hilmioglu F. Effect of Helicobacter pylori eradication on peptic ulcer disease complicated with outlet obstruction. Helicobacter. 2000;5:38.
33. Gibson JB, Behrman SW, Fabian TC, Brito LG. Gastric outlet obstruction resulting from peptic ulcer disease requiring surgical intervention is infrecuently associated with Helicobacter pylori infection. J Am Coll Surg. 2000;191:32.
34. Boilan JJ, Gradzka MI. Long term results of endoscopic balloon dilatation for gastric outlet obstruction. Dig Dis Sci. 1999;44:1883.